Michael Edward Woodman

Title: Michael Edward Woodman: Innovator in Pharmaceutical Science

Introduction

Michael Edward Woodman is a notable inventor based in Fishers, Indiana. He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for autoimmune diseases. His innovative work has led to the creation of a patent that addresses critical health issues.

Latest Patents

Michael holds a patent for IL-17A inhibitors. This invention provides certain difluorocyclohexyl-imidazopyridazinyl-imidazolidinone compounds of formula II as IL-17A inhibitors. The patent outlines pharmaceutical compositions and methods for using these compounds to treat symptoms of psoriasis, rheumatoid arthritis, and multiple sclerosis. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Michael is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development, where he focuses on innovative solutions for complex medical conditions. His work at Eli Lilly has positioned him as a key player in the pharmaceutical industry.

Collaborations

Throughout his career, Michael has collaborated with talented professionals, including David Andrew Coates and Kwame Frimpong. These collaborations have enhanced his research and contributed to the advancement of pharmaceutical innovations.

Conclusion

Michael Edward Woodman exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the development of IL-17A inhibitors, highlight his commitment to improving patient outcomes. His work continues to inspire advancements in medical science.